Steve Tutewohl's most recent trade in Evolent Health Inc - Ordinary Shares - Class A was a trade of 9,000 Class A Common Stock done . Disclosure was reported to the exchange on July 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 9,000 | 136,331 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 17,011 | 132,707 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.15 per share. | 01 Mar 2023 | 3,200 | 127,331 (0%) | 0% | 35.2 | 112,480 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.26 per share. | 01 Mar 2023 | 2,176 | 130,531 (0%) | 0% | 35.3 | 76,726 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 14,300 | 120,470 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.08 per share. | 21 Feb 2023 | 4,774 | 115,696 (0%) | 0% | 28.1 | 134,054 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.12 per share. | 01 Jul 2022 | 2,251 | 106,170 (0%) | 0% | 31.1 | 70,051 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.30 per share. | 03 Mar 2022 | 1,918 | 108,421 (0%) | 0% | 27.3 | 52,361 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.54 per share. | 02 Mar 2022 | 4,499 | 110,339 (0%) | 0% | 27.5 | 123,902 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 20,000 | 118,843 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.29 per share. | 01 Mar 2022 | 5,388 | 121,130 (0%) | 0% | 13.3 | 71,607 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 5,388 | 5,388 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.41 per share. | 01 Mar 2022 | 5,388 | 114,838 (0%) | 0% | 27.4 | 147,685 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.40 per share. | 01 Mar 2022 | 4,005 | 114,838 (0%) | 0% | 27.4 | 109,737 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.85 per share. | 03 Feb 2022 | 1,707 | 98,843 (0%) | 0% | 22.9 | 39,005 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.47 per share. | 01 Feb 2022 | 6,313 | 100,550 (0%) | 0% | 23.5 | 148,166 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 6,313 | 0 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.95 per share. | 01 Feb 2022 | 6,313 | 106,863 (0%) | 0% | 13.9 | 88,066 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 01 Sep 2021 | 13,553 | 100,550 (0%) | 0% | 25.1 | 339,503 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 13,801 | 6,313 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 13,801 | 114,103 (0%) | 0% | 23.0 | 317,699 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.95 per share. | 02 Aug 2021 | 13,801 | 127,904 (0%) | 0% | 14.0 | 192,524 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 11,229 | 0 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 11,229 | 114,103 (0%) | 0% | 23.0 | 258,492 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.25 per share. | 02 Aug 2021 | 11,229 | 125,332 (0%) | 0% | 18.2 | 204,929 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 3,331 | 114,103 (0%) | 0% | 23.0 | 76,680 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.95 per share. | 02 Aug 2021 | 3,331 | 117,434 (0%) | 0% | 13.9 | 46,467 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 3,331 | 20,114 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.02 per share. | 02 Aug 2021 | 2,625 | 114,103 (0%) | 0% | 23.0 | 60,428 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.25 per share. | 02 Aug 2021 | 2,625 | 116,728 (0%) | 0% | 18.2 | 47,906 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 2,625 | 11,229 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.52 per share. | 09 Jul 2021 | 10,576 | 114,103 (0%) | 0% | 22.5 | 238,172 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 10,576 | 10,776 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.29 per share. | 09 Jul 2021 | 10,576 | 124,679 (0%) | 0% | 13.3 | 140,555 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 1,808 | 23,445 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 09 Jul 2021 | 1,808 | 114,103 (0%) | 0% | 23 | 41,584 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.95 per share. | 09 Jul 2021 | 1,808 | 115,911 (0%) | 0% | 14.0 | 25,222 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 1,465 | 13,854 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 09 Jul 2021 | 1,465 | 114,103 (0%) | 0% | 23 | 33,695 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.25 per share. | 09 Jul 2021 | 1,465 | 115,568 (0%) | 0% | 18.2 | 26,736 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 08 Jul 2021 | 200 | 114,103 (0%) | 0% | 22 | 4,400 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 200 | 21,352 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.29 per share. | 08 Jul 2021 | 200 | 114,303 (0%) | 0% | 13.3 | 2,658 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.05 per share. | 01 Jul 2021 | 9,352 | 114,103 (0%) | 0% | 21.1 | 196,860 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 9,352 | 18,702 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.83 per share. | 01 Jul 2021 | 9,352 | 123,455 (0%) | 0% | 7.8 | 73,226 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.48 per share. | 03 May 2021 | 9,943 | 114,103 (0%) | 0% | 21.5 | 213,576 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.83 per share. | 03 May 2021 | 9,352 | 123,455 (0%) | 0% | 7.8 | 73,226 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 9,352 | 28,054 | - | - | Class A Common Stock Option (right to buy) | |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.49 per share. | 03 May 2021 | 9,352 | 114,103 (0%) | 0% | 21.5 | 200,974 | Class A Common Stock |
| Evolent Health Inc Ordinary | Steve Tutewohl | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 31,000 | 124,046 (0%) | 0% | 0 | Class A Common Stock |